Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 35 results.
User Information
Export Records
  1. 1.   PLS-a-GalCer: a novel targeted glycolipid therapy for solid tumors
  2. Burks, Julian; Tiwary, Shweta; Stevens, David M; Skoczen,Sarah; Kularatne,Ruvanthi Nilanga; Stern,Stephan; Berzofsky, Jay A
  3. Journal for Immunotherapy of Cancer. 2025, Mar 22; 13(3):
  1. 2.   Carbohydrate antigen microarray analysis of serum IgG and IgM antibodies before and after adult porcine islet xenotransplantation in cynomolgus macaques
  2. Nanno, Yoshihide; Sterner, Eric; Gildersleeve,Jeffrey; Hering, Bernhard J.; Burlak, Christopher
  3. PLOS ONE. 2021, Jun 17; 16(6):
  1. 3.   Crystal structures of beta-1,4-galactosyltransferase 7 enzyme reveal conformational changes and substrate binding
  2. Tsutsui, Y.; Ramakrishnan, B.; Qasba, P. K.
  3. Journal of Biological Chemistry. 2013, 1-Nov; 288(44): 31963-70.
  1. 4.   The N-acetyl-binding pocket of N-acetylglucosaminyltransferases also accommodates a sugar analog with a chemical handle at C2
  2. Pasek, M.; Ramakrishnan, B.; Boeggeman, E.; Mercer, N.; Dulcey, A. E.; Griffiths, G. L.; Qasba, P. K.
  3. Glycobiology. 2012, Mar; 22(3): 379-388.
  1. 5.   Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1
  2. Borges, A. R.; Wieczorek, L.; Johnson, B.; Benesi, A. J.; Brown, B. K.; Kensinger, R. D.; Krebs, F. C.; Wigdahl, B.; Blumenthal, R.; Puri, A.; McCutchan, F. E.; Birx, D. L.; Polonis, V. R.; Schengrund, C. L.
  3. Virology. 2010, Dec; 408(1): 80-88.
  1. 6.   Crystal Structure of the Catalytic Domain of Drosophila beta 1,4-Galactosyltransferase-7
  2. Ramakrishnan, B.; Qasba, P. K.
  3. Journal of Biological Chemistry. 2010, May; 285(20): 15619-15626.
  1. 7.   Bioconjugation and detection of lactosamine moiety using alpha1,3-galactosyltransferase mutants that transfer C2-modified galactose with a chemical handle
  2. Pasek, M.; Ramakrishnan, B.; Boeggeman, E.; Manzoni, M.; Waybright, T. J.; Qasba, P. K.
  3. Bioconjugate Chemistry. 2009, Mar 18; 20(3): 608-18.
  1. 8.   Deoxygenated Disaccharide Analogs as Specific Inhibitors of beta 1-4-Galactosyltransferase 1 and Selectin-mediated Tumor Metastasis
  2. Brown, J. R.; Yang, F.; Sinha, A.; Ramakrishnan, B.; Tor, Y.; Qasba, P. K.; Esko, J. D.
  3. Journal of Biological Chemistry. 2009 284(8): 4952-4959.
  1. 9.   Application of tissue-specific NK and NKT cell activity for tumor immunotherapy
  2. Subleski, J. J.; Wiltrout, R. H.; Weiss, J. M.
  3. Journal of Autoimmunity. 2009, Nov-Dec; 33(3-4): 275-281.
  1. 10.   Glycoside analogs of beta-galactosylceramide, a novel class of small molecule antiviral agents that inhibit HIV-1 entry
  2. Garg, H.; Francella, N.; Tony, K. A.; Augustine, L. A.; Barchi, J. J.; Fantini, J.; Puri, A.; Mootoo, D. R.; Blumenthal, R.
  3. Antiviral Research. 2008 80(1): 54-61.
  1. 11.   Site-specific linking of biomolecules via glycan residues using Glycosyltransferases
  2. Qasba, P. K.; Boeggeman, E.; Ramakrishnan, B.
  3. Biotechnology Progress. 2008 24(3): 520-526.
  1. 12.   Structure and Function of beta-1,4-Galactosyltransferase
  2. Qasba, P. K.; Ramakrishnan, B.; Boeggeman, E.
  3. Current Drug Targets. 2008 9(4): 292-309.
  1. 13.   Letter to the Glyco-Forum: Catalytic domains of glycosyltransferases with 'add-on' domains
  2. Qasba, P. K.; Ramakrishnan, B.
  3. Glycobiology. 2007, May; 17(5): 7G-9G.
  1. 14.   Direct identification of nonreducing GlcNAc residues on N-glycans of glycoproteins using a novel chemoenzymatic method
  2. Boeggeman, E.; Ramakrishnan, B.; Kilgore, C.; Khidekel, N.; Hsieh-Wilson, L. C.; Simpson, J. T.; Qasba, P. K.
  3. Bioconjugate Chemistry. 2007, May-Jun; 18(3): 806-814.
  1. 15.   Role of a single amino acid in the evolution of glycans of invertebrates and vertebrates
  2. Ramakrishnan, B.; Qasba, P. K.
  3. Journal of Molecular Biology. 2007, Jan; 365(3): 570-576.
  1. 16.   A novel soluble mimic of the glycolipid, globotriaosyl ceramide inhibits HIV infection
  2. Lund, N.; Branch, D. R.; Mylvaganam, M.; Chark, D.; Ma, X. Z.; Sakac, D.; Binnington, B.; Fantini, J.; Puri, Z.; Blumenthal, R.; Lingwood, C.
  3. Aids. 2006, Feb; 20(3): 333-343.
  1. 17.   Mutant glycosyltransferases assist in the development of a targeted drug delivery system and contrast agents for MRI
  2. Qasba, P. K.; Ramakrishnan, B.; Boeggeman, E.
  3. Aaps Journal. 2006 8(1): E190-E195.
  1. 18.   Oligosaccharide preferences of beta 1,4-galactosyltransferase-I: Crystal structures of Met340His mutant of human beta 1,4-galactosyltransferase-I with a pentasaccharide and trisaccharides of the N-glycan moiety
  2. Ramasamy, V.; Ramakrishnan, B.; Boeggeman, E.; Ratner, D. M.; Seeberger, P. H.; Qasba, P. K.
  3. Journal of Molecular Biology. 2005, OCT 14; 353(1): 53-67.
  1. 19.   Sphingolipids: Modulators of HIV-1 infection and pathogenesis
  2. Rawat, S. S.; Johnson, B. T.; Puri, A.
  3. Bioscience Reports. 2005, OCT; 25(5-6): 329-343.
  1. 20.   Mutation of arginine 228 to lysine enhances the glucosyltransferase activity of bovine beta-1,4-galactosyltransferase I
  2. Ramakrishnan, B.; Boeggeman, E.; Qasba, P. K.
  3. Biochemistry. 2005, MAR 8; 44(9): 3202-3210.
  1. 21.   Effect of the Met344His mutation on the conformational dynamics of bovine beta-1,4-galactosyltransferase: Crystal structure of the Met344His mutant in complex with chitobiose
  2. Ramakrishnan, B.; Boeggeman, E.; Qasba, P. K.
  3. Biochemistry. 2004, OCT 5; 43(39): 12513-12522.
  1. 22.   Structure and catalytic cycle of beta-1,4-galactosyltransferase
  2. Ramakrishnan, B.; Boeggeman, E.; Ramasamy, V.; Qasba, P. K.
  3. Current Opinion in Structural Biology. 2004, OCT; 14(5): 593-600.
  1. 23.   Marine natural products and related compounds in clinical and advanced preclinical trials
  2. Newman, D. J.; Cragg, G. M.
  3. Journal of Natural Products. 2004, AUG; 67(8): 1216-1238.
  1. 24.   Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides
  2. Ortaldo, J. R.; Young, H. A.; Winkler-Pickett, R. T.; Bere, E. W.; Murphy, W. J.; Wiltrout, R. H.
  3. Journal of Immunology. 2004 172(2): 943-953.
  1. 25.   Comparison of the closed conformation of the beta 1,4- galactosyltransferase-1 (beta 4Gal-T1) in the presence and absence of alpha-lactalbumin (LA)
  2. Ramakrishnan, B.; Qasba, P. K.
  3. Journal of Biomolecular Structure & Dynamics. 2003 21(1): 1-8.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel